bloating on retatrutide Urgent warning as 'illegal Triple G' fat jabs dubbed the 'Godzilla' of weight loss injections flood UK Retatrutide vs Tirzepatide | FIRST

Most users begin to experience reduced cravings and improved appetite control within the first 2 to 4 weeks

The most commonly studied GLP-1RA was liraglutide, followed by semaglutide, dulaglutide, tirzepatide, and several others

When it is elevated, fat cells preferentially store fatty acids rather than release them

This triple mechanism distinguishes retatrutide from existing approved weight loss peptides such as semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GIP/GLP-1 receptor agonist), although direct head-to-head trials comparing these agents have not been conducted, and comparative efficacy has not been established